
Sign up to save your podcasts
Or


Dr. Iyad Alnahhas interviews Dr. Nathalie Albert about her and her team's recent manuscript entitled: "Measurable disease as baseline criterion for response in glioblastoma: A comparison of PET-based (PET RANO 1.0) and MRI-based (RANO) assessments", published online in Neuro-Oncology in January 2025.
By Neuro-Oncology4.8
1212 ratings
Dr. Iyad Alnahhas interviews Dr. Nathalie Albert about her and her team's recent manuscript entitled: "Measurable disease as baseline criterion for response in glioblastoma: A comparison of PET-based (PET RANO 1.0) and MRI-based (RANO) assessments", published online in Neuro-Oncology in January 2025.

30,687 Listeners

43,741 Listeners

7,707 Listeners

10,749 Listeners

318 Listeners

291 Listeners

3,349 Listeners

112,946 Listeners

56,549 Listeners

10,293 Listeners

9,202 Listeners

5,477 Listeners

16,095 Listeners

18,033 Listeners

10,254 Listeners